For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230728:nRSb4772Ha&default-theme=true
RNS Number : 4772H Norman Broadbent PLC 28 July 2023
Norman Broadbent plc
("Norman Broadbent or the "Company")
Grant of Options
and
Director/PDMR Shareholding
Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and
Interim Management firm offering a diversified portfolio of integrated
Leadership Acquisition & Advisory Services, announces that, on 28 July
2023 (the "Date of Grant"), it granted options over, in aggregate, 4,148,148
ordinary shares of £0.01 each ("Ordinary Shares") in the Company ("Options")
to both Executive Directors and certain employees (the "Grant") under its
Enterprise Management Incentive Option Scheme 2022 (the "Scheme"). The Options
are exercisable at nil pence per Ordinary Share.
The Options granted under the Scheme vest over a 3-year period (25 per cent.
of the Grant are deemed to have vested on 18 March 2023*). Once vested, the
Options can be exercised within 7 years of the Date of Grant date subject to
the following two sets of performance criteria:
· 50 per cent. of the vested Options are exercisable on a scaled
basis following the price of an Ordinary Share achieving an average of between
10p and 19p over any three-month period prior to 30 June 2026 ("Share Price
Vesting Options"); and
· The remaining 50 per cent. of the vested Options are exercisable
on a scaled basis following the achievement by the Company of audited EBITDA
in the range of greater than £500,000 to £1,250,000 in any financial year
from the Date of Grant to 31 December 2025 ("EBITDA Vesting Options").
The following table sets out details of the Options that have been granted to
the Executive Directors and one person discharging managerial responsibilities
("PDMR"):
Percentage of the Company's Existing Issued Shares Under Option held Percentage of the Company's Fully Diluted Share Capital held**
Number of Share Price Vesting Options granted Number of EBITDA Vesting Options granted Total Number of Options granted Total Number of Options held following Grant
Name of Individual
Director/PDMR
Kevin Davidson CEO 299,076 299,072 598,148 2,548,148 4.1% 3.4%
Mehr Malik CFO 850,000 850,000 1,700,000 1,700,000 2.8% 2.3%
Sean Bergin COO and PDMR 125,000 125,000 250,000 1,700,000 2.8% 2.3%
Total 1,274,076 1,274,072 2,548,148 5,948,148 9.7% 8.0%
*anniversary of original grant of options
**assuming that no further Ordinary Shares are issued between the date of this
announcement and the exercise of the Options.
In addition, a further 1,600,000 options over Ordinary Shares have been
granted to certain of the Company's employees.
Following the Grant, there are 12,148,148 options over Ordinary Shares
outstanding representing 19.7 per cent. of the Company's issued share capital.
At the date of this announcement, the Company has 61,817,543 Ordinary Shares
in issue.
The FCA notification, made in accordance with the requirements of the UK
Market Abuse Regulation is appended further below.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name
Kevin Davidson CEO
Mehr Malik CFO
Sean Bergin COO
2 Reason for the notification
a) Position/status See 1a) above
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Norman Broadbent Plc
b) LEI 213800E5YN5TA934XA23
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of £0.01 each in Norman Broadbent Plc
Identification code Identification code (ISIN) for Norman Broadbent Plc ordinary shares:
GB00B3VF4Y66
b) Nature of the transaction Grant of options
c) Price(s) and volume(s) Name Price(s) Volume(s)
Kevin Davidson nil 598,148
Mehr Malik nil 1,700,000
Sean Bergin nil 250,000
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transactions Options put in place as of 28 July 2023
f) Place of the transaction Outside a trading venue
2
Reason for the notification
a)
Position/status
See 1a) above
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Norman Broadbent Plc
b)
LEI
213800E5YN5TA934XA23
4
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Options over ordinary shares of £0.01 each in Norman Broadbent Plc
Identification code (ISIN) for Norman Broadbent Plc ordinary shares:
GB00B3VF4Y66
b)
Nature of the transaction
Grant of options
c)
Price(s) and volume(s)
Name Price(s) Volume(s)
Kevin Davidson nil 598,148
Mehr Malik nil 1,700,000
Sean Bergin nil 250,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transactions
Options put in place as of 28 July 2023
f)
Place of the transaction
Outside a trading venue
This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.
For further information, please contact:
Norman Broadbent plc +44
(0) 20 7484 0000
Kevin Davidson, CEO
Mehr Malik, CFO
Shore Capital (Nominated Adviser and Broker)
020 7408 4090
Tom Griffiths / Tom Knibbs (Corporate Advisory)
Henry Willcocks (Corporate Broking)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBLGDRBSDDGXR